Carcinoma, Papillary

• 

  Subject Areas on Research

  • A Bedside Risk Calculator to Preoperatively Distinguish Follicular Thyroid Carcinoma from Follicular Variant of Papillary Thyroid Carcinoma. 
  • A Gastric Glycoform of MUC5AC Is a Biomarker of Mucinous Cysts of the Pancreas. 
  • A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma. 
  • A meta-analysis of the effect of prophylactic central compartment neck dissection on locoregional recurrence rates in patients with papillary thyroid cancer. 
  • A novel integrative risk index of papillary thyroid cancer progression combining genomic alterations and clinical factors. 
  • A pilot case-control study of gamma-radiation sensitivity and risk of papillary thyroid cancer. 
  • Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer. 
  • Aggressive variants of papillary thyroid cancer. 
  • Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients. 
  • Aggressive variants of papillary thyroid microcarcinoma are associated with extrathyroidal spread and lymph-node metastases: a population-level analysis. 
  • American Thyroid Association Guidelines on the Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and Recommendation on the Proposed Renaming of Encapsulated Follicular Variant Papillary Thyroid Carcinoma Without Invasion to Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features. 
  • American Thyroid Association design and feasibility of a prospective randomized controlled trial of prophylactic central lymph node dissection for papillary thyroid carcinoma. 
  • An exponential growth in incidence of thyroid cancer: trends and impact of CT imaging. 
  • An unusual presentation of thyroid papillary carcinoma: enlargement of a cervical intervertebral foramen. 
  • An update on noninvasive follicular thyroid neoplasm with papillary-like nuclear features. 
  • An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC). 
  • Applying Criteria of Active Surveillance to Low-Risk Papillary Thyroid Cancer Over a Decade: How Many Surgeries and Complications Can Be Avoided? 
  • Association of BRCA1 functional single nucleotide polymorphisms with risk of differentiated thyroid carcinoma. 
  • BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer. 
  • BRAFV600E mutation in papillary thyroid microcarcinoma: a genotype-phenotype correlation. 
  • Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid cancer. 
  • Can minimally invasive follicular thyroid cancer be approached as a benign lesion?: a population-level analysis of survival among 1,200 patients. 
  • Central lymph node dissection in patients with papillary thyroid cancer: a population level analysis of 14,257 cases. 
  • Cervical lymph node metastasis and papillary thyroid carcinoma: does the compartment involved affect survival? Experience from the SEER database. 
  • Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas. 
  • Clonality analysis of multifocal papillary thyroid carcinoma by using genetic profiles. 
  • Combined positron emission tomography - computed tomography improves specificity for thyroid carcinoma by identifying vocal cord activity after laryngeal nerve paralysis. 
  • Current Controversy of Radiographic Surveillance of Patients With Branch-duct IPMN and Pancreatic Cysts: Commentary on: Ductal Carcinoma Arising in a Largely Unchanged Presumed Branch Duct IPMN After 10 Years of Surveillance. 
  • Current Guidelines for Postoperative Treatment and Follow-Up of Well-Differentiated Thyroid Cancer. 
  • Cytologically low grade malignancies: an important interpretative pitfall responsible for false negative diagnoses in fine-needle aspiration of the breast. 
  • Defining Papillary Carcinoma of the Thyroid: A Short Review and Analysis. 
  • Delayed treatment of papillary thyroid carcinoma arising from struma ovarii in a patient with history of bilateral salpingo-oophorectomy: a case report. 
  • Detection of Circulating BRAF(V600E) in Patients with Papillary Thyroid Carcinoma. 
  • Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium. 
  • Dysplasia at the surgical margin is associated with recurrence after resection of non-invasive intraductal papillary mucinous neoplasms. 
  • Effect of Tumor Size on Risk of Metastatic Disease and Survival for Thyroid Cancer: Implications for Biopsy Guidelines. 
  • Evaluation of cervical lymph nodes in head and neck cancer with CT and MRI: tips, traps, and a systematic approach. 
  • Exploring the Relationship Between Patient Age and Cancer-Specific Survival in Papillary Thyroid Cancer: Rethinking Current Staging Systems. 
  • Exposure to flame retardant chemicals and occurrence and severity of papillary thyroid cancer: A case-control study. 
  • Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients. 
  • Extrathyroidal Extension Is Associated with Compromised Survival in Patients with Thyroid Cancer. 
  • Fortuitous detection of papillary carcinoma of the thyroid with F-18 FDG positron emission tomography in a patient with non-Hodgkin lymphoma. 
  • Functional variations in the ATM gene and susceptibility to differentiated thyroid carcinoma. 
  • GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma. 
  • Gastrin-releasing peptide gene expression in developing, hyperplastic, and neoplastic human thyroid C-cells. 
  • Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications. 
  • Hobnail variant of papillary thyroid carcinoma: an institutional case series and molecular profile. 
  • How Many Lymph Nodes Are Enough? Assessing the Adequacy of Lymph Node Yield for Papillary Thyroid Cancer. 
  • I-131, I-123, and F-18 FDG-PET imaging in a patient with diffuse sclerosing variant of papillary thyroid cancer. 
  • Imaging-guided core needle biopsy of papillary lesions of the breast. 
  • Immunocytochemistry for SOX-11 and TFE3 as diagnostic markers for solid pseudopapillary neoplasms of the pancreas in FNA biopsies. 
  • Immunoglobulin localization in benign and malignant lesions of the human mammary gland. 
  • Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years. 
  • In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease. 
  • Incidental metastatic papillary thyroid carcinoma in microvascular reconstruction. 
  • Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival. 
  • Iodine quantification to distinguish clear cell from papillary renal cell carcinoma at dual-energy multidetector CT: a multireader diagnostic performance study. 
  • Is routine prophylactic central neck dissection indicated for low-risk papillary thyroid cancer: can we determine cost-effectiveness if we are unsure about its effectiveness and safety? 
  • Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer. 
  • LGR5 is associated with tumor aggressiveness in papillary thyroid cancer. 
  • Low-Grade Papillary Schneiderian Carcinoma of the Sinonasal Cavity and Temporal Bone. 
  • Lymphovascular invasion is associated with survival for papillary thyroid cancer. 
  • Malignant progression in IPMN: a cohort analysis of patients initially selected for resection or observation. 
  • Measurement and Variation in Estimation of Quality of Life Effects of Patients Undergoing Treatment for Papillary Thyroid Carcinoma. 
  • Micropapillary thyroid carcinoma and concomitant ectopic thyroid tissue in the adrenal gland: metastasis or metaplasia? 
  • Mitochondrial DNA alterations in thyroid cancer. 
  • Modified radical mastectomy with immediate reconstruction for carcinoma of the breast. 
  • Molecular Testing of Nodules with a Suspicious or Malignant Cytologic Diagnosis in the Setting of Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP). 
  • Molecular genetics and histopathologic features of adult distal nephron tumors. 
  • Molecular testing for indeterminate thyroid nodules: Performance of the Afirma gene expression classifier and ThyroSeq panel. 
  • Noninvasive Follicular Variant of Papillary Thyroid Carcinoma and the Afirma Gene-Expression Classifier. 
  • Obesity is associated with worse overall survival in women with low-grade papillary serous epithelial ovarian cancer. 
  • Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutation. 
  • Outcomes in surgical stage I uterine papillary serous carcinoma. 
  • Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas. 
  • Pancreatic cyst fluid protein expression profiling for discriminating between serous cystadenoma and intraductal papillary mucinous neoplasm. 
  • Papillary Thyroid Microcarcinoma: An Over-Treated Malignancy?: Reply. 
  • Papillary carcinoma of the breast: imaging findings. 
  • Papillary thyroid cancer. 
  • Patients Treated at Low-Volume Centers have Higher Rates of Incomplete Resection and Compromised Outcomes: Analysis of 31,129 Patients with Papillary Thyroid Cancer. 
  • Patients with follicular and Hurthle cell microcarcinomas have compromised survival: a population level study of 22,738 patients. 
  • Patterns of Initial Recurrence in Completely Resected Papillary Thyroid Carcinoma. 
  • Patterns of use and cost for inappropriate radioactive iodine treatment for thyroid cancer in the United States: use and misuse. 
  • Predicting dysplasia and invasive carcinoma in intraductal papillary mucinous neoplasms of the pancreas: development of a preoperative nomogram. 
  • Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer. 
  • Prevalence of Contralateral Tumors in Patients with Follicular Variant of Papillary Thyroid Cancer. 
  • Primary carcinoma of the upper urinary tract. Effect of primary and secondary therapy on survival. 
  • Primary thyroid-like low-grade nasopharyngeal papillary adenocarcinoma: A case report and literature review. 
  • Progression of disease despite good endoscopic local control of upper tract urothelial carcinoma. 
  • Projecting Survival in Papillary Thyroid Cancer: A Comparison of the Seventh and Eighth Editions of the American Joint Commission on Cancer/Union for International Cancer Control Staging Systems in Two Contemporary National Patient Cohorts. 
  • Qualifiers of atypia in the cytologic diagnosis of thyroid nodules are associated with different Afirma gene expression classifier results and clinical outcomes. 
  • Recurrence patterns of intraductal papillary mucinous neoplasms of the pancreas on enhanced computed tomography. 
  • Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. 
  • Revisiting overdiagnosis and fatality in thyroid cancer. 
  • Risk factors for ovarian cancers with and without microsatellite instability. 
  • Robotic thyroidectomy for cancer in the US: patterns of use and short-term outcomes. 
  • SOX9: a useful marker for pancreatic ductal lineage of pancreatic neoplasms. 
  • Serum levels of HER-2 neu (C-erbB-2) correlate with overexpression of p185neu in human ovarian cancer. 
  • Should all branch-duct intraductal papillary mucinous neoplasms be resected? 
  • Significance of MDM2 and P14 ARF polymorphisms in susceptibility to differentiated thyroid carcinoma. 
  • Single nucleotide polymorphisms act as modifiers and correlate with the development of medullary and simultaneous medullary/papillary thyroid carcinomas in 2 large, non-related families with the RET V804M proto-oncogene mutation. 
  • Solid pseudo-papillary tumors of the pancreas: current update. 
  • Sonographic Detection of Extracapsular Extension in Papillary Thyroid Cancer. 
  • Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes. 
  • Sternal metastasis as first presentation of a well-differentiated papillary thyroid carcinoma. 
  • Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades. 
  • Suspicious ultrasound characteristics predict BRAF V600E-positive papillary thyroid carcinoma. 
  • Tall cell variant of papillary thyroid microcarcinoma: clinicopathologic features with BRAF(V600E) mutational analysis. 
  • The Flip Side of NIFTP: an Increase in Rates of Unfavorable Histologic Parameters in the Remainder of Papillary Thyroid Carcinomas. 
  • The Impact of Noninvasive Follicular Variant of Papillary Thyroid Carcinoma on Rates of Malignancy for Fine-Needle Aspiration Diagnostic Categories. 
  • The Impact of Pathologically Positive Lymph Nodes in the Clinically Negative Neck: An Analysis of 39,301 Patients with Papillary Thyroid Cancer. 
  • The changing incidence of thyroid cancer. 
  • The changing landscape of papillary thyroid cancer: Epidemiology, management, and the implications for patients. 
  • The management of intraductal papillary mucinous neoplasms of the pancreas. 
  • The utility of thyroglobulin washout studies in predicting cervical lymph node metastases: One academic medical center's experience. 
  • Therapeutic management of intracystic papillary carcinoma of the breast: the roles of radiation and endocrine therapy. 
  • Thyroglossal duct cyst carcinoma: case report and review of the literature. 
  • Thyroid malignancy masquerading as thyroiditis. 
  • Thyroid neoplasia following irradiation for medulloblastoma: report of two cases. 
  • Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013. 
  • Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patients. 
  • Tumor-associated Neutrophils and Malignant Progression in Intraductal Papillary Mucinous Neoplasms: An Opportunity for Identification of High-risk Disease. 
  • Ultrasound of the thyroid and parathyroid glands. 
  • Unbalanced 5;16 translocation in a boy with papillary thyroid carcinoma. 
  • Uncinate duct dilation in intraductal papillary mucinous neoplasms of the pancreas: a radiographic finding with potentially increased malignant potential. 
  • Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity. 
  • Vanishing thyroid tumors: a diagnostic dilemma after ultrasonography-guided fine-needle aspiration. 
  • What Is the Optimal Treatment of Papillary Thyroid Cancer? 
  • Whole-body Tc-99m sestamibi scintigraphy in the follow-up of differentiated thyroid carcinoma. 
• 

  Keywords of People

  • Berchuck, Andrew, James M. Ingram Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology